So here's what we have to look forward to
In the next trading week, audited financials should be posted for all to see, thus removing anyone's fears that TDGI isn't a real company and never intended to file audited financials - or if they even did them for that matter. Also, thus proving that they are a legitimate pink sheet company willing to file audited financials for the necessary transparency for more investors to invest.
We also are expecting in the short term news about Terminator T3000. We haven't seen a retraction from Hannover House nor have we seen any statement from Pacificor, the hedge fund they're negotiating with. We do know the cease and desist letter was retracted the next day via the most recent filing on pink sheets (wonder why some folks conveniently leave this important piece of info from the filing out... whoops): We also know that as of this writing, 13 business days has passed since TDGI and Pacificor first met to discuss the possibility of doing the project. That bodes well for those wanting to see TDGI get to do T3000 since our CEO has the animation rights to the Terminator franchise. 13 business days and not a word. Advantage, longs.
We also look forward to Q2 filings that may contain the latest valuation of their library to include 2010 acquisitions/deals. End of the quarter is only 3 weeks away, then maybe we'll have them at some point in October. If the library valuation is updated in this filing, this will be the largest event to occur to date for Hannover House. That valuation could be a game changer for trading at these levels if book value is established at multiples of where we're trading. No way it's going to be anywhere near our current PPS either way. Advantage, longs.
Also, per Speckulater's post recapping a snippet from the most recent filing, we apparently also have to shortly look forward to uplisting news.
It is the company’s intention to use the full audits from Hogan Taylor to initiate the required steps to become a fully-compliant / fully-reporting company, and thus facilitate and expedite the opportunities to move onto the OTC-Bulletin Board or other trading exchanges.
